European Journal of Medicinal Chemistry · 2022 · 12 citations · 13 references
PharmacyMedicinal ChemistryPharmacologyBioisosterismDrug DiscoveryMetabolic StabilityChagas DiseaseCombinatorial SynthesisMetabolic Stability EnhancementMetabolic Stability OptimizationPotency OptimizationProtozoan Host-parasite InteractionsAnthelmintic Drug DiscoveryAntiparasitic Drug DiscoveryBioisosteric OptimizationDrug Discovery For AnthelminticsIsosteric ReplacementsParasite Metabolism In InfectionTreatment Of TrypanosomiasisTrypanosoma Cruzi Infection
Approximately 6-7 million people around the world are estimated to be infected with Trypanosoma cruzi, the causative agent of Chagas disease. The current treatments are inadequate and therefore new medical interventions are urgently needed. In this paper we describe the identification of a series of disubstituted piperazines which shows good potency against the target parasite but is hampered by poor metabolic stability. We outline the strategies used to mitigate this issue such as lowering logD, bioisosteric replacements of the metabolically labile piperazine ring and use of plate-based arrays for quick diversity scoping. We discuss the success of these strategies within the context of this series and highlight the challenges faced in phenotypic programs when attempting to improve the pharmacokinetic profile of compounds whilst maintaining potency against the desired target.
13
Theo Vos, Stephen S Lim, Cristiana Abbafati et al. · The Lancet · 2020 · 19.2K citations · Full text
Nanomole-scale high-throughput chemistry for the synthesis of complex molecules
A. Buitrago Santanilla, Erik L. Regalado, Tony Pereira et al. · Science · 2014 · 649 citations
Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · The Lancet Infectious Diseases · 2018 · 297 citations · Full text